Negative Side of Supply-Side Economics
This article is posted in:
Three poignant cases where over-supply (of docs) leads to over-testing or over-treating
screening
Screening Test?
This article is posted in:Some risk factors are NOT worthwhile to use as screening tests.... Many risk factors for disease are suggested as screening tests when there is no prospect that they could be useful in screening. To avoid this it is useful to know the quantitative equivalence between the value of a risk factor and its screening performance in terms of the detection rate (sensitivity) for a specified false-positive rate.
Early Detection Does Not Help in Breast Cancer? Wrong!
This article is posted in:Do you believe the authors of an European study who assert that "while screening may reduce cervical and colorectal cancer mortality, it's not so for breast cancer"? [BMJ July 28, 2011] Neither do I. According to an August 3rd, 2011 [last acccessed 8/7/11] Medscape editorial by Fran Lowry. The "conclusions of the BMJ study authors have little bearing on, or resemblance to, screening in the United States.
What's Non-emergent?
This article is posted in:I believe there are 2 schools of thought. One is benefit limitation and the second is managing "non emergent" presentations with a triage payment for screening the patient. This LinkedIn MCO Executive's discussion was begun by Charita Harmon, MSN
Patient Delay in Breast Cancer Detection
Delayed presentation of self-discovered breast symptoms influences stage of cancer at diagnosis and decreases breast cancer survival. Methods A total of 699 asymptomatic women (black, white, and Latino), recruited in community settings and stratified by age, income, and educational level, were surveyed for their likelihood to delay (J-Delay scale) in the event of a breast symptom discovery. Models of likelihood were tested with logistic regression analyses.
